Month: September 2020

Global deaths from Covid-19 are accelerating, as the worldwide death toll approaches 1 million. The World Health Organization reported deaths rose by 8% last week compared to the week before, with more than 40,600 fatalities recorded. The U.S., Brazil and India account for the largest shares of that cumulative total, with the U.S. alone accounting
0 Comments
Working with dot-counting mice running through a virtual-reality maze, scientists from Harvard Medical School have found that in order to navigate space rodent brains rely on a cascade of neural signals that culminate in a single decision that prompts the animal to choose one direction over another. Read the full story: http://hms.harvard.edu/news/maze-runners Like Harvard Medical
0 Comments
 As of 2020, 33 states have legalized at least one form of cannabis; its use is spreading across all age ranges of adults.  Several studies have shown surprisingly strong uptake by senior citizens across the country, increasing each year. As many as 1 in 20 senior citizens in America are exploring marijuana products. Let’s take
0 Comments
We share some stories reminding us that beauty and hope continues to thrive in difficult circumstances and how you can take time to notice it This year, going online has become somewhat of a risky endeavour. You never know if you’re going to come away feeling connected and empowered, or lost and despondent. As I
0 Comments
So far, no therapies have proven to be safe and effective for children who develop life-threatening complications from COVID-19. That might be changing. Researchers at the Children’s Hospital of Philadelphia (CHOP) published findings last week that suggest convalescent plasma could work as a treatment for pediatric patients with severe cases of the coronavirus. People who
0 Comments
The long-awaited post-marketing studies of the abuse-deterrent formulation (ADF) of OxyContin (Perdue Pharma L.P.) received mixed reviews from a US Food and Drug Administration (FDA) joint advisory committee. After a two-day discussion of new research submitted by Perdue, as well as other relevant published data, most members of the Drug Safety and Risk Management (DSaRM)
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 14 2020 Scientists have shown that the babies of mothers dealing with anxiety or depression exhibit physiologically stronger signs of stress than babies of healthy mothers, when given a standard stress test. These babies show a significantly increased heart rate, which researchers fear may lead to imprinted emotional stresses as
0 Comments
tepotinib Treatment for Non-Small Cell Lung Cancer FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment of Patients with Metastatic NSCLC with METex14 Skipping Alterations Print this page ROCKLAND, Mass., Aug. 25, 2020 /PRNewswire/ – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that the US Food and Drug
0 Comments
Print this page London UK 9 September 2020 — GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol ‘FF/UMEC/VI’) for the treatment of asthma in patients aged 18 years and older adding to
0 Comments
Health officials and epidemiologists will be watching U.S. infection trends closely this week for any early indications of a potential spike in cases brought on by the Labor Day holiday weekend. Steady economic reopening — including the resumption later this month of indoor dining in New York City, the original U.S. hot spot of the virus — could
0 Comments
Deutetrabenazine (Austedo) showed maintained efficacy for tardive dyskinesia (TD) symptoms over a 3-year period, researchers reported. In an open-label extension study of two 12-week clinical trials, 73% patients on deutetrabenazine maintained treatment success 3 years after initial dosing based on Clinical Global Impression of Change (CGIC), reported Robert Hauser, MD, MBA, of the University of
0 Comments
Can exercise make you smarter? It can, say researchers from Sweden. According to their research, published today in Translational Sports Medicine , “ aerobic, physical exercise before encoding improves learning and memory functions in young adults.”   It’s common for young adults to spend hours sitting through seminars or sifting through documentation with breaks for
0 Comments
The investigational drug, masitinib (AB Science), which has a completely new mechanism of action for multiple sclerosis (MS), has shown a positive result in slowing disability in patients with primary progressive and secondary progressive forms of the disease and no signs of active inflammation in a phase 2b/3 study. “This is the first time that
0 Comments
The photos of wildfires in the West are eery. Orange skies in San Francisco and surrounding areas are caused by fires more than 200 miles away as smoke and flames filter out the sunlight. But orange skies aren’t the only thing that can reach beyond the fires – so can smoke and ash as they
0 Comments
“It is time that the prodromal phase of multiple sclerosis is formally recognized.” That was the conclusion of Helen Tremlett, PhD, delivering the opening plenary session lecture at the 8th Joint European Committee for Treatment and Research in Multiple Sclerosis-Americas Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS-ACTRIMS) 2020, this year known as MSVirtual2020.
0 Comments
Posted on August 28, 2020 by Mari Evans COVID-19 has forced all of us to rethink how we interact with the world and each other. Still, staying connected remains vital to our well-being. At Atria Senior Living, we believe people belong together. By making adjustments to Atria’s Engage Life® events program, team members continue to
0 Comments
Dr. Robert Redfield, Director of the Centers for Disease Control and Prevention speaks while U.S. President Donald Trump listens during the daily briefing of the coronavirus task force at the White House on April 22, 2020 in Washington, DC. Drew Angerer | Getty Images Public health specialists and the medical community are criticizing the Trump
0 Comments
Reviewed by Emily Henderson, B.Sc.Sep 12 2020 New research shows improving the lifestyle of women with obesity during pregnancy could mean long-term cardiovascular benefits for their children. The study, led by King’s College London and supported by the British Heart Foundation and Tommy’s charity, examined how an antenatal diet and physical activity intervention in pregnant
0 Comments